# Shebli Atrash, M.D. – FDA Inspection, Mar 16, 2023

Source: https://www.keypedia.com/records/fda_inspections/shebli-atrash-md/e9ce8994-73d2-4b6d-b556-8774e907b959
Source feed: FDA_Inspections

> FDA inspection 1201134 of Shebli Atrash, M.D., March 16, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201134
- Company Name: Shebli Atrash, M.D.
- Inspection Date: 2023-03-16
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Tracy R. Ball](https://www.keypedia.com/people/tracy-r-ball/cc74ec9d-796b-4820-bc20-333d98775d01)

Company: https://www.keypedia.com/companies/shebli-atrash-md/9360ce56-9f56-4f21-adb4-1e474adbc6c4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c